beta-TrCP binding and processing of NF-kappaB2/p100 involve its phosphorylation at serines 866 and 870.
about
SUMO1 modification of NF-kappaB2/p100 is essential for stimuli-induced p100 phosphorylation and processingThe Ubiquitination of NF-κB Subunits in the Control of TranscriptionThe Regulation of NF-κB Subunits by PhosphorylationNF-κB, the first quarter-century: remarkable progress and outstanding questionsNon-Canonical NF-κB Signaling Initiated by BAFF Influences B Cell Biology at Multiple JuncturesThe restrained expression of NF-kB in renal tissue ameliorates folic acid induced acute kidney injury in miceTCR signaling to NF-κB and mTORC1: Expanding roles of the CARMA1 complexNFKB2 mutation in common variable immunodeficiency and isolated adrenocorticotropic hormone deficiency: A case report and review of literatureGermline mutations in NFKB2 implicate the noncanonical NF-κB pathway in the pathogenesis of common variable immunodeficiencybeta-TrCP inhibition reduces prostate cancer cell growth via upregulation of the aryl hydrocarbon receptor.Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatasesT cell-intrinsic function of the noncanonical NF-κB pathway in the regulation of GM-CSF expression and experimental autoimmune encephalomyelitis pathogenesis.ATM regulates NF-κB-dependent immediate-early genes via RelA Ser 276 phosphorylation coupled to CDK9 promoter recruitment.The noncanonical NF-κB pathway.Negative regulation of NF-κB activity by brain-specific TRIpartite Motif protein 9.Autosomal-dominant B-cell deficiency with alopecia due to a mutation in NFKB2 that results in nonprocessable p100.Proteomic screen reveals Fbw7 as a modulator of the NF-κB pathway.The Transitional Endoplasmic Reticulum ATPase p97 Regulates the Alternative Nuclear Factor NF-κB Signaling via Partial Degradation of the NF-κB Subunit p100.A dominant-negative F-box deleted mutant of E3 ubiquitin ligase, β-TrCP1/FWD1, markedly reduces myeloma cell growth and survival in mice.RelB: an outlier in leukocyte biology.AMPKα1 deletion in fibroblasts promotes tumorigenesis in athymic nude mice by p52-mediated elevation of erythropoietin and CDK2.Non-canonical NF-κB signaling pathway.The kinase NIK as a therapeutic target in multiple myeloma.Nuclear factor-kappa B inhibitors; a patent review (2006-2010).A novel role for the proteasomal chaperone PSMD9 and hnRNPA1 in enhancing IκBα degradation and NF-κB activation - functional relevance of predicted PDZ domain-motif interaction.The non-canonical NF-κB pathway in immunity and inflammation.Regulation of Ci-SCFSlimb binding, Ci proteolysis, and hedgehog pathway activity by Ci phosphorylation.Negative role of TAK1 in marginal zone B-cell development incidental to NF-κB noncanonical pathway activation.New insights into NF-kappaB regulation and function.Controlling the fate of NIK: a central stage in noncanonical NF-kappaB signaling.Active NIK:p-S176;180-IKKA dimer phosphorylates p100:RELBSCF-beta-TRCP binds p-7S-p100 in active NIK:p-S176;180-IKKA dimer:p-7S-p100:RELBThe NFKB Inducing Kinase Modulates Hematopoiesis During Stress.Novel NFKB2 mutation in early-onset CVID.Targeting IKKβ in Cancer: Challenges and Opportunities for the Therapeutic Utilisation of IKKβ Inhibitors
P2860
Q24312155-60AD2941-F7EC-47D8-A9ED-EDC3C0455E55Q26748938-EFFFA428-B037-47F5-A996-5A0576ADAB77Q26752951-56D9742A-8F62-45D4-819F-BAC5A8FA61F3Q26822516-FD909987-E234-4D96-A6FE-4F026E4D8980Q27024640-8D5AFC5A-2CE4-4C00-B6DC-DF645E99141EQ27318623-7762CC7A-0619-402E-A58E-59DBC2FD5304Q28085394-8D980120-2EA4-4258-BBF3-34080E6DDA84Q28279175-86208200-F10A-4DA0-BF9A-FD203D71A6B7Q28300499-A2DC31D7-AF97-4E95-8884-5A9BAECC1BC5Q33530099-B18D6A6A-8322-4F02-8EDF-6D4DE513780AQ33636430-C67B7844-0522-4AD1-AE4C-ADC0A3550FFBQ33827244-C04DCEFB-896C-4CA4-BBFE-EB70DBEAC4F8Q33983560-9D6D1B24-4611-410E-A04C-7897FCF7A009Q34031207-25B6EA9D-7809-46AB-975A-82FDC0C31E52Q34147534-3D54BDCE-814F-4E48-A9A9-4C5557071475Q35062895-234C200F-88D8-446E-9E3B-799330E960A8Q35160414-D80B4D4B-46E0-4009-9D52-AF1BF8BC354AQ35925801-1F89D659-B7B4-4C07-BED9-8ECD63496A83Q36356398-6076A299-5F3A-43B4-BAB1-4D0F3DCBEC15Q37238291-BDC39E86-6C9A-4BE0-8606-36DCE2856EF6Q37619809-03C08453-0419-43EE-9B9B-B2A0637928B6Q37822660-B2974CE2-4D51-4B02-B76A-D0D0CBB750BFQ37825898-168BC376-717B-41ED-837A-2A819355265EQ37958061-EE11E738-825F-4511-9DE4-E927B7020FDDQ39005586-D34FD347-9B17-45FD-AC46-2DE00A81EC64Q39350735-337B8173-DED3-45EF-BCF5-39A27F106D43Q39721420-C3F4343E-7E5D-4C83-8F10-2A39BF1FB475Q41522612-AF6A86FC-3050-4E41-8045-89B81F66AF2EQ47097632-8017E84B-1593-4A63-8F1D-D1AB34084EE5Q47148976-ED271D1D-71A5-45D7-A976-E3BBAD0D3589Q50292290-4910C1AE-54EC-4447-A615-EF7E5E7E1FF6Q50292291-794CF86B-95FD-4B08-BF5D-8A66A352036AQ50443743-151DA07E-FEE5-47F9-8F07-0C096BBD9C42Q50802065-64C3C374-4041-423F-9992-98714C0FA0F3Q57167736-315B5D14-DCDA-43BE-BBAE-C7D37317AFA3
P2860
beta-TrCP binding and processing of NF-kappaB2/p100 involve its phosphorylation at serines 866 and 870.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
beta-TrCP binding and processi ...... lation at serines 866 and 870.
@en
beta-TrCP binding and processi ...... lation at serines 866 and 870.
@nl
type
label
beta-TrCP binding and processi ...... lation at serines 866 and 870.
@en
beta-TrCP binding and processi ...... lation at serines 866 and 870.
@nl
prefLabel
beta-TrCP binding and processi ...... lation at serines 866 and 870.
@en
beta-TrCP binding and processi ...... lation at serines 866 and 870.
@nl
P2093
P1433
P1476
beta-TrCP binding and processi ...... lation at serines 866 and 870.
@en
P2093
Chunyang Liang
Minying Zhang
Shao-Cong Sun
P304
P356
10.1016/J.CELLSIG.2005.10.011
P577
2005-11-21T00:00:00Z